NCT06800677View on ClinicalTrials.gov

Methylated Biomarkers Predictive of Endometrial Cancer Risk

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Endometrial Cancer
Interventions
PROCEDURE

Hysterectomy

Elective hysterectomy

Trial Locations (1)

M13 9WL

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
collaborator

Queen Mary University of London

OTHER

lead

University of Manchester

OTHER

NCT06800677 - Methylated Biomarkers Predictive of Endometrial Cancer Risk | Biotech Hunter | Biotech Hunter